Evidence explorer
Every claim we hold, and how far we can stand behind it.
142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.
What this corpus is made of
| Evidence class | Claims | Confirmed | What it can support |
|---|---|---|---|
| Peer-reviewed study | 19 | 5 | Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting. |
| Regulatory filing | 4 | 0 | A statement made to a regulator, where being wrong has consequences. |
| Independent report | 32 | 9 | Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately. |
| Customer case | 4 | 3 | A real deployment, but selected and framed by someone with an interest. |
| Press release | 63 | 22 | The vendor's own announcement. Useful for dates and facts, not for outcomes. |
| Vendor page | 20 | 1 | Marketing copy. Establishes what is claimed, never that it is true. |
Showing 1 of 1 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters
AKASA raised $120M in 2024, earning a spot on TechCrunch's list of 49 U.S. AI startups that raised $100M+ in 2024; the company reports more than $200M raised to date from investors including a16z, BOND, and Costanoa.
Provenance
- Claim ID
- clm_299f9fc8c2c1ceb76474
- Version
- 1
- Workflow
- Revenue Cycle / Coding / Prior Auth
- Dimension
- market durability
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://techcrunch.com/2024/12/20/heres-the-full-list-of-49-us-ai-startups-that-have-raised-100m-or-more-in-2024/